The role of the thrombospondins in healing myocardial infarcts

Khaled Chatila, Guofeng Ren, Ying Xia, Peter Huebener, Marcin Bujak, Nikolaos G. Frangogiannis

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The five current members of the thrombospondin (TSP) family can be divided in two subgroups according to their molecular architecture. TSP-1 and -2 (subgroup A) are trimeric matricellular proteins that do not contribute directly to tissue integrity, but influence cell function by modulating cell-matrix interactions, whereas TSP-3, -4 and -5 (subgroup B) are pentameric proteins. TSP-1 and TSP-2 are markedly induced in healing wounds and may regulate cellular responses important for tissue repair. TSP-1 is a crucial activator of TGF-β, whereas both TSP-1 and TSP-2 inhibit angiogenesis. This manuscript reviews our current knowledge on the expression and role of the TSPs in healing myocardial infarcts. In both canine and murine infarcts, TSP-1 shows a strikingly selective localization in the infarct border zone. In the absence of injury, TSP-1 -/- mice exhibit normal cardiac morphology and show no evidence of myocardial inflammation. Infarcted TSP-1 -/- mice have an enhanced and protracted inflammatory response with subsequent expansion of granulation tissue in the non-infarcted area, resulting in myofibroblast infiltration into the viable myocardium neighboring the infarct. Infarcted TSP-1 -/- animals have enhanced left ventricular remodeling compared with their wildtype littermates. We suggest that TSP-1 is a critical component of the protective mechanisms induced in the infarct border zone in order to limit expansion of fibrosis into the non-infarcted myocardium. Localized TSP-1 expression may suppress expansion of the inflammatory process by activating TGF-β or by inhibiting local angiogenesis. In addition, TSP-1-mediated inhibition of MMP activity may decrease adverse remodeling. TSP-2, on the other hand, appears to be a crucial regulator of the integrity of the cardiac matrix that is necessary for the myocardium to cope with increased loading. The expression and potential role of the pentameric TSPs in the infarcted heart remain unknown. Understanding the specific mechanisms responsible for the protective effects of TSP-1 and TSP-2 in healing infarcts may lead to novel therapeutic interventions aiming at attenuating adverse left ventricular remodeling.

Original languageEnglish (US)
Pages (from-to)21-27
Number of pages7
JournalCardiovascular and Hematological Agents in Medicinal Chemistry
Volume5
Issue number1
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Thrombospondin 1
Thrombospondins
Myocardial Infarction
Myocardium
Ventricular Remodeling
Myofibroblasts
Granulation Tissue
Matrix Metalloproteinases
Cell Communication
Wound Healing
Canidae
Fibrosis
thrombospondin 2
Inflammation

Keywords

  • Angiogenesis
  • Extracellular matrix
  • Infarction
  • inflammation
  • Remodeling
  • TGF-β
  • Thrombospondins
  • Wound healing

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology
  • Pharmacology

Cite this

Chatila, K., Ren, G., Xia, Y., Huebener, P., Bujak, M., & Frangogiannis, N. G. (2007). The role of the thrombospondins in healing myocardial infarcts. Cardiovascular and Hematological Agents in Medicinal Chemistry, 5(1), 21-27.

The role of the thrombospondins in healing myocardial infarcts. / Chatila, Khaled; Ren, Guofeng; Xia, Ying; Huebener, Peter; Bujak, Marcin; Frangogiannis, Nikolaos G.

In: Cardiovascular and Hematological Agents in Medicinal Chemistry, Vol. 5, No. 1, 01.2007, p. 21-27.

Research output: Contribution to journalArticle

Chatila, K, Ren, G, Xia, Y, Huebener, P, Bujak, M & Frangogiannis, NG 2007, 'The role of the thrombospondins in healing myocardial infarcts', Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 5, no. 1, pp. 21-27.
Chatila, Khaled ; Ren, Guofeng ; Xia, Ying ; Huebener, Peter ; Bujak, Marcin ; Frangogiannis, Nikolaos G. / The role of the thrombospondins in healing myocardial infarcts. In: Cardiovascular and Hematological Agents in Medicinal Chemistry. 2007 ; Vol. 5, No. 1. pp. 21-27.
@article{8dab55c31de64a18adef07c0a62c6f91,
title = "The role of the thrombospondins in healing myocardial infarcts",
abstract = "The five current members of the thrombospondin (TSP) family can be divided in two subgroups according to their molecular architecture. TSP-1 and -2 (subgroup A) are trimeric matricellular proteins that do not contribute directly to tissue integrity, but influence cell function by modulating cell-matrix interactions, whereas TSP-3, -4 and -5 (subgroup B) are pentameric proteins. TSP-1 and TSP-2 are markedly induced in healing wounds and may regulate cellular responses important for tissue repair. TSP-1 is a crucial activator of TGF-β, whereas both TSP-1 and TSP-2 inhibit angiogenesis. This manuscript reviews our current knowledge on the expression and role of the TSPs in healing myocardial infarcts. In both canine and murine infarcts, TSP-1 shows a strikingly selective localization in the infarct border zone. In the absence of injury, TSP-1 -/- mice exhibit normal cardiac morphology and show no evidence of myocardial inflammation. Infarcted TSP-1 -/- mice have an enhanced and protracted inflammatory response with subsequent expansion of granulation tissue in the non-infarcted area, resulting in myofibroblast infiltration into the viable myocardium neighboring the infarct. Infarcted TSP-1 -/- animals have enhanced left ventricular remodeling compared with their wildtype littermates. We suggest that TSP-1 is a critical component of the protective mechanisms induced in the infarct border zone in order to limit expansion of fibrosis into the non-infarcted myocardium. Localized TSP-1 expression may suppress expansion of the inflammatory process by activating TGF-β or by inhibiting local angiogenesis. In addition, TSP-1-mediated inhibition of MMP activity may decrease adverse remodeling. TSP-2, on the other hand, appears to be a crucial regulator of the integrity of the cardiac matrix that is necessary for the myocardium to cope with increased loading. The expression and potential role of the pentameric TSPs in the infarcted heart remain unknown. Understanding the specific mechanisms responsible for the protective effects of TSP-1 and TSP-2 in healing infarcts may lead to novel therapeutic interventions aiming at attenuating adverse left ventricular remodeling.",
keywords = "Angiogenesis, Extracellular matrix, Infarction, inflammation, Remodeling, TGF-β, Thrombospondins, Wound healing",
author = "Khaled Chatila and Guofeng Ren and Ying Xia and Peter Huebener and Marcin Bujak and Frangogiannis, {Nikolaos G.}",
year = "2007",
month = "1",
language = "English (US)",
volume = "5",
pages = "21--27",
journal = "Cardiovascular and Hematological Agents in Medicinal Chemistry",
issn = "1871-5257",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - The role of the thrombospondins in healing myocardial infarcts

AU - Chatila, Khaled

AU - Ren, Guofeng

AU - Xia, Ying

AU - Huebener, Peter

AU - Bujak, Marcin

AU - Frangogiannis, Nikolaos G.

PY - 2007/1

Y1 - 2007/1

N2 - The five current members of the thrombospondin (TSP) family can be divided in two subgroups according to their molecular architecture. TSP-1 and -2 (subgroup A) are trimeric matricellular proteins that do not contribute directly to tissue integrity, but influence cell function by modulating cell-matrix interactions, whereas TSP-3, -4 and -5 (subgroup B) are pentameric proteins. TSP-1 and TSP-2 are markedly induced in healing wounds and may regulate cellular responses important for tissue repair. TSP-1 is a crucial activator of TGF-β, whereas both TSP-1 and TSP-2 inhibit angiogenesis. This manuscript reviews our current knowledge on the expression and role of the TSPs in healing myocardial infarcts. In both canine and murine infarcts, TSP-1 shows a strikingly selective localization in the infarct border zone. In the absence of injury, TSP-1 -/- mice exhibit normal cardiac morphology and show no evidence of myocardial inflammation. Infarcted TSP-1 -/- mice have an enhanced and protracted inflammatory response with subsequent expansion of granulation tissue in the non-infarcted area, resulting in myofibroblast infiltration into the viable myocardium neighboring the infarct. Infarcted TSP-1 -/- animals have enhanced left ventricular remodeling compared with their wildtype littermates. We suggest that TSP-1 is a critical component of the protective mechanisms induced in the infarct border zone in order to limit expansion of fibrosis into the non-infarcted myocardium. Localized TSP-1 expression may suppress expansion of the inflammatory process by activating TGF-β or by inhibiting local angiogenesis. In addition, TSP-1-mediated inhibition of MMP activity may decrease adverse remodeling. TSP-2, on the other hand, appears to be a crucial regulator of the integrity of the cardiac matrix that is necessary for the myocardium to cope with increased loading. The expression and potential role of the pentameric TSPs in the infarcted heart remain unknown. Understanding the specific mechanisms responsible for the protective effects of TSP-1 and TSP-2 in healing infarcts may lead to novel therapeutic interventions aiming at attenuating adverse left ventricular remodeling.

AB - The five current members of the thrombospondin (TSP) family can be divided in two subgroups according to their molecular architecture. TSP-1 and -2 (subgroup A) are trimeric matricellular proteins that do not contribute directly to tissue integrity, but influence cell function by modulating cell-matrix interactions, whereas TSP-3, -4 and -5 (subgroup B) are pentameric proteins. TSP-1 and TSP-2 are markedly induced in healing wounds and may regulate cellular responses important for tissue repair. TSP-1 is a crucial activator of TGF-β, whereas both TSP-1 and TSP-2 inhibit angiogenesis. This manuscript reviews our current knowledge on the expression and role of the TSPs in healing myocardial infarcts. In both canine and murine infarcts, TSP-1 shows a strikingly selective localization in the infarct border zone. In the absence of injury, TSP-1 -/- mice exhibit normal cardiac morphology and show no evidence of myocardial inflammation. Infarcted TSP-1 -/- mice have an enhanced and protracted inflammatory response with subsequent expansion of granulation tissue in the non-infarcted area, resulting in myofibroblast infiltration into the viable myocardium neighboring the infarct. Infarcted TSP-1 -/- animals have enhanced left ventricular remodeling compared with their wildtype littermates. We suggest that TSP-1 is a critical component of the protective mechanisms induced in the infarct border zone in order to limit expansion of fibrosis into the non-infarcted myocardium. Localized TSP-1 expression may suppress expansion of the inflammatory process by activating TGF-β or by inhibiting local angiogenesis. In addition, TSP-1-mediated inhibition of MMP activity may decrease adverse remodeling. TSP-2, on the other hand, appears to be a crucial regulator of the integrity of the cardiac matrix that is necessary for the myocardium to cope with increased loading. The expression and potential role of the pentameric TSPs in the infarcted heart remain unknown. Understanding the specific mechanisms responsible for the protective effects of TSP-1 and TSP-2 in healing infarcts may lead to novel therapeutic interventions aiming at attenuating adverse left ventricular remodeling.

KW - Angiogenesis

KW - Extracellular matrix

KW - Infarction

KW - inflammation

KW - Remodeling

KW - TGF-β

KW - Thrombospondins

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=33846043111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846043111&partnerID=8YFLogxK

M3 - Article

C2 - 17266545

AN - SCOPUS:33846043111

VL - 5

SP - 21

EP - 27

JO - Cardiovascular and Hematological Agents in Medicinal Chemistry

JF - Cardiovascular and Hematological Agents in Medicinal Chemistry

SN - 1871-5257

IS - 1

ER -